Vasopressin formulations for use in treatment of hypotension

CAFC
  • US 9,750,785 B2
  • Filed: 02/07/2017
  • Issued: 09/05/2017
  • Est. Priority Date: 01/30/2015
  • Status: Active Grant
First Claim
Patent Images

1. A pharmaceutical composition comprising, in a unit dosage form, from about 0.01 mg/mL to about 0.07 mg/mL of vasopressin or a pharmaceutically-acceptable salt thereof, wherein the unit dosage form further comprises impurities that are present in an amount of 0.9% to 1.7%, wherein the impurities have from about 85% to about 100% sequence homology to SEQ ID NO.:

  • 1, and wherein the unit dosage form has a pH of 3.7-3.9.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×